• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物群的功能。

Function of the microbiota.

机构信息

Department for Biotechnology and Biochemical Engineering, Faculty of Technology and Metallurgy, University of Belgrade, Karnegijeva 4, 11000 Belgrade, Serbia.

出版信息

Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):5-16. doi: 10.1016/j.bpg.2013.03.006.

DOI:10.1016/j.bpg.2013.03.006
PMID:23768548
Abstract

The gut microbiota of humans is complex but stable in composition and function. Metabolic conversions performed by the members of the microbiota yield both beneficial and hazardous compounds, and have a systematic impact on human health. Comparative studies have shown that the microbiota of patients, suffering from a number of diseases, is in dysbiosis, which is characterized by a distinct composition. Compositional differences have also been noted between members of geographically distant healthy populations. To be able to identify which compositional changes promote compromised health, it is of interest to identify members of the microbiota that perform essential metabolic transformations. This review provides an insight into the microbial contribution to the metabolism of carbohydrates, proteins and bile acids, and focuses on the link between diversity and function.

摘要

人类的肠道微生物群组成复杂,但在组成和功能上都很稳定。微生物群成员进行的代谢转化既产生有益的化合物,也产生有害的化合物,并对人类健康产生系统的影响。比较研究表明,患有多种疾病的患者的微生物群处于失调状态,其特征是组成明显不同。在地理上相隔甚远的健康人群中,也注意到了组成上的差异。为了能够确定哪些组成变化会促进健康受损,确定执行必要代谢转化的微生物群成员是很有意义的。这篇综述深入探讨了微生物对碳水化合物、蛋白质和胆汁酸代谢的贡献,并重点关注了多样性和功能之间的联系。

相似文献

1
Function of the microbiota.微生物群的功能。
Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):5-16. doi: 10.1016/j.bpg.2013.03.006.
2
Glycobiome: bacteria and mucus at the epithelial interface.糖生物组学:上皮界面的细菌和黏液
Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):25-38. doi: 10.1016/j.bpg.2013.03.001.
3
Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.在 CKD 进展过程中,肠道氨基酸代谢紊乱与肠道微生物失调和宏基因组变化有关。
J Pharm Biomed Anal. 2018 Feb 5;149:425-435. doi: 10.1016/j.jpba.2017.11.040. Epub 2017 Nov 15.
4
Gut microbiota and bile acids: an old story revisited (again).
Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):129-31. doi: 10.1016/j.clinre.2013.06.006. Epub 2013 Jul 31.
5
The human microbiome: from symbiosis to pathogenesis.人类微生物组:从共生到发病机制。
Annu Rev Med. 2013;64:145-63. doi: 10.1146/annurev-med-010312-133513.
6
The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.调控肠道微生物群在肥胖和 2 型糖尿病中的治疗潜力。
Diabetes Obes Metab. 2012 Feb;14(2):112-20. doi: 10.1111/j.1463-1326.2011.01483.x. Epub 2011 Nov 22.
7
The gut microbiota, obesity and insulin resistance.肠道微生物群、肥胖和胰岛素抵抗。
Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16.
8
Prebiotic effects: metabolic and health benefits.益生元作用:代谢与健康益处。
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
9
Interactions of gut microbiota with functional food components and nutraceuticals.肠道微生物群与功能性食品成分和营养保健品的相互作用。
Pharmacol Res. 2010 Mar;61(3):219-25. doi: 10.1016/j.phrs.2009.11.001. Epub 2009 Nov 13.
10
Gut microbiota, host health, and polysaccharides.肠道微生物群、宿主健康和多糖。
Biotechnol Adv. 2013 Mar-Apr;31(2):318-37. doi: 10.1016/j.biotechadv.2012.12.009. Epub 2012 Dec 30.

引用本文的文献

1
Gut Microbiota in Women with Eating Disorders: A New Frontier in Pathophysiology and Treatment.饮食失调女性的肠道微生物群:病理生理学与治疗的新前沿
Nutrients. 2025 Jul 14;17(14):2316. doi: 10.3390/nu17142316.
2
A narrative review of research advances in gut microbiota and microecological agents in children with attention deficit hyperactivity disorder (ADHD).注意缺陷多动障碍(ADHD)患儿肠道微生物群与微生态制剂研究进展的叙述性综述
Front Psychiatry. 2025 May 23;16:1588135. doi: 10.3389/fpsyt.2025.1588135. eCollection 2025.
3
Beyond the Brain: Attention Deficit/Hyperactivity Disorder and the Gut-Brain Axis.
超越大脑:注意力缺陷/多动障碍与肠脑轴
Cureus. 2024 Dec 23;16(12):e76291. doi: 10.7759/cureus.76291. eCollection 2024 Dec.
4
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.中药和膳食化合物对肝纤维化中肠道微生物群调节作用的研究综述
Heliyon. 2024 Sep 26;10(19):e38339. doi: 10.1016/j.heliyon.2024.e38339. eCollection 2024 Oct 15.
5
The comparison of gut microbiota between wild and captive Asian badgers (Meles leucurus) under different seasons.野生和圈养亚洲獾(Meles leucurus)在不同季节的肠道微生物群比较。
Sci Rep. 2024 Aug 6;14(1):18199. doi: 10.1038/s41598-024-69277-8.
6
Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence.膳食多酚、微生物组与多发性硬化症:从分子抗炎和神经保护机制到临床证据。
Int J Mol Sci. 2023 Apr 14;24(8):7247. doi: 10.3390/ijms24087247.
7
Polysaccharides Modulate Immunity and Gut Microbiota in Immunocompromised Mice.多糖调节免疫功能低下小鼠的免疫和肠道菌群。
Oxid Med Cell Longev. 2023 Feb 15;2023:6208680. doi: 10.1155/2023/6208680. eCollection 2023.
8
prebiotic activities of oligosaccharides from the by-products in spore polysaccharide extraction.孢子多糖提取副产物中低聚糖的益生元活性
RSC Adv. 2020 Apr 14;10(25):14794-14802. doi: 10.1039/c9ra10798c. eCollection 2020 Apr 8.
9
Probiotics, Their Extracellular Vesicles and Infectious Diseases.益生菌、其细胞外囊泡与传染病
Front Microbiol. 2022 Mar 30;13:864720. doi: 10.3389/fmicb.2022.864720. eCollection 2022.
10
Alterations in common marmoset gut microbiome associated with duodenal strictures.与十二指肠狭窄相关的普通绒猴肠道微生物组的改变。
Sci Rep. 2022 Mar 28;12(1):5277. doi: 10.1038/s41598-022-09268-9.